| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.22 | 9e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |